Scientific and regulatory issues relevant to assessing risk for developmental neurotoxicity: an overview.
The effects of chemical exposure on the developing nervous system have been documented in both humans and animals for a variety of agents. However, the comparability of these effects has not been carefully evaluated to determine the predictability of animal models to adverse effects in humans. A workshop sponsored by the U.S. Environmental Protection Agency (EPA) and the National Institute on Drug Abuse was held on April 11-13, 1989, to address the Qualitative and Quantitative Comparability of Human and Animal Developmental Neurotoxicity. Invited experts were asked to review the human and animal data on several agents that are known to cause developmental neurotoxicity in humans, including lead, methylmercury, selected abused agents, anticonvulsants, polychlorinated biphenyls (PCBs), ethanol and X-irradiation, and to make quantitative comparisons on a specific end point basis as well as on a functional category basis. In addition, they were asked to make quantitative comparisons when adequate dose-effect data were available. The data also were evaluated in the context of the proposed EPA developmental neurotoxicity testing battery to determine whether or not the battery would adequately detect the effects of each agent. Finally, four work groups were asked to reach consensus on issues relating to: 1) comparability of end points across species for developmental neurotoxicity; 2) testing methods in developmental neurotoxicity for use in human risk assessment; 3) weight-of-evidence and quantitative evaluation of data from developmental neurotoxicity studies; and 4) triggers for developmental neurotoxicity testing.
Rees
D C
DC
Health and Environmental Review Division, United States Environmental Protection Agency, Washington, DC 24060.
Francis
E Z
EZ
Kimmel
C A
CA
D000818:Animals; D005260:Female; D006077:Government Agencies; D006801:Humans; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000196:embryology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012306:Risk; D014481:United States